CDEK
← All drugs Report issue

krill oil

Animal productexperimental

Krill oil is an extract prepared from a species of Antarctic krill, Euphausia superba. Processed krill oil is commonly sold as a dietary supplement. Two components of krill oil are omega-3 fatty acids similar to those in fish oil, and phospholipid-derived fatty acids (PLFA), mainly phosphatidylcholine. Fishing for krill where previously the focus was on marine life of higher trophic level is an example of fishing down the food web. — Wikipedia

Clinical trial activity

45 trials · 52 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
7
Phase 3
3
Phase 4
4

Earliest trial started Jan 1, 2008 (NCT00732576)

Timeline

2010s

  1. Jan 1, 2011

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2012

    Earliest Phase 3 Sponsor(trial)

  3. Jan 1, 2013

    Earliest Phase 1 Sponsor(trial)

Indications

Approved for

Studied for

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • capre
  • krill oil

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07130513N/AAug 18, 2025University of Glasgow
NCT06880926Phase 2Apr 1, 2025Shandong University
NCT06939244N/AFeb 1, 2025University of Glasgow
NCT06580912Phase 2Oct 14, 2024National Institute on Aging (NIA), University of Florida
NCT06331195N/AAug 31, 2024Hospital do Coracao, Instituto Dante Pazzanese de Cardiologia, National Institute of Cardiology, Laranjeiras, Brazil, University of Sao Paulo
NCT06296875N/AJul 31, 2024University of Glasgow
NCT06151548Phase 4Apr 30, 2024Poznan University
NCT06271434N/AMar 23, 2024Poznan University
NCT06005064N/ANov 1, 2023University of Glasgow
NCT05695937N/AMay 22, 2023Federal University of Health Science of Porto Alegre, Federal University of Sao Paulo, Hospital do Coracao, National Institute of Cardiology, Laranjeiras, Brazil, University of Sao Paulo
NCT05869513N/AMay 5, 2023University of Glasgow
NCT05774444N/AMay 1, 2023University of Glasgow
NCT05869526N/AMay 1, 2023University of Glasgow
NCT05677074N/AJan 1, 2023University of Copenhagen
NCT05465252N/AAug 31, 2022Jiao Tong University
NCT05438173N/AJul 11, 2022MB Clinical Research and Consulting LLC, Midwest Center for Metabolic and Cardiovascular Research, Naturmega
NCT06001632N/AMar 28, 2022University of Glasgow
NCT04943523N/AAug 31, 2021Dasman Diabetes Institute
NCT04347421N/AApr 10, 2020Pusan National University
NCT04279743N/AApr 1, 2020University of Sherbrooke
Showing 20 of 45 trials
Page 1 / 3

Organizations

Research & Development (52)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
University of GlasgowAcademic/Hospital9912018
Aker Biomarine Antarctic ASFor profit4312011
Acasti Pharma Inc.For profit3322011
Tufts UniversityAcademic/Hospital3122015
Hospital do CoracaoAcademic/Hospital2212023
National Institute of Cardiology, Laranjeiras, BrazilGovernment2012023
Olympic Seafood ASFor profit2012014
Poznan UniversityAcademic/Hospital2222024
University of Sao PauloAcademic/Hospital2012023
Aker BioMarine Human Ingredients ASFor profit1112012
Ampel BioSolutions, LLCFor profit1012018
BioTeSys GmbHFor profit1012012
Commonwealth Scientific and Industrial Research Organisation, AustraliaGovernment1012018
Dasman Diabetes InstituteAcademic/Hospital1112021
EnzymotecFor profit1012011
Federal University of Health Science of Porto AlegreAcademic/Hospital1012023
Federal University of Sao PauloAcademic/Hospital1012023
Gottfried Wilhelm Leibniz Universität HannoverAcademic/Hospital1112010
Hospitalet ValdemarAcademic/Hospital1112013
Instituto Dante Pazzanese de CardiologiaAcademic/Hospital1012024
52 organizations
Page 1 / 3